Advertisement

Topics

Pharm-Olam International Company Profile

23:58 EST 11th December 2018 | BioPortfolio

Pharm-Olam International started operations in 1994 with the premise of delivering cost-effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries across five continents, including North America, Western Europe, Central & Eastern Europe, Latin America, Asia, and Africa. Today, POI has one of the largest global footprints of any CRO. We are committed to establishing and maintaining the industry's strongest multi-national presence. Our monitors have the most extensive knowledge of local and regional across a broad range of therapeutic areas. You can be absolutely confident that your trials are in reliable hands.
POI has an entirely different model than other CROs— We call it global decentralization. The success of this model has been proven time and again.
Your study deserves the superior management experience and clinical trial expertise of Pharm-Olam International. We are focused and committed to improving life by providing excellence in clinical research.

Location

450 N. Sam Houston Parkway, Suite 250
Houston
Texas
77060
United States of America

Contact

Phone: 1 (713) 463-8075
Fax: 1 (713) 463-8281
Email: info@pharm-olam.com


News Articles [462 Associated News Articles listed on BioPortfolio]

‘Every patient counts’: Pharm-Olam on orphan disease trial that led to approval

After Pharm-Olam conducted an orphan disease trial for therapy for a rare blood disorder, the European Commission granted it marketing authorization, and FDA is to give it priority review.

Pharm-Olam International Supports Clinical Trials and Sponsors Compliance with GDPR

Pharm-Olam International, a global, full-service contract research organization (CRO) specializing in oncology, infectious diseases and vaccines, rare and orphan diseases,...

Pharm-Olam Conducts Pivotal Orphan Disease Trial, Leads to First Therapeutic Approved for the Treatment for Acquired Thrombotic Thrombocytopenic Purpura

Pharm-Olam, a global, midsized CRO offering full-service clinical development solutions for oncology, infectious diseases and vaccines, and rare and orphan diseases, extend...

Medidata teams with Pharm-Olam

CRO hopes partnership will accelerate drugs' time to market

YiChang HEC Pharm Raises $400 Million from Blackstone Group

YiChang HEC ChangJiang Pharm raised $400 million from Blackstone Group in the a convertible bond offering. The bonds will pay 3%. HEC Pharm, based in Yichang in central China’s Hubei province, w...

Cannbit to sell medical cannabis to Tikun Olam

Tikun Olam will be short of cannabis until its Kfar Yehoshua farms is approved.

Pharm-Olam Unifies Data on Medidata Cloud, Eliminating Silos

CRO accelerates the delivery of life-changing therapies with a single view of data for all clinical trial stakeholders Pharm-Olam unifies operational systems sup...

Ark Pharm’s Shady Side

Once in a while we have discussions of chemical suppliers around here – but we haven’t had one like this. On Friday afternoon, word came out that Ark Pharm, a reasonably well-known firm ou...

Clinical Trials [1078 Associated Clinical Trials listed on BioPortfolio]

Vitamin D Supplementation and and Glycemic Indexes

Age affect insulin sensitivity and the metabolism, and vitamin D status was shown to have a correlation with markers of insulin resistance. That's why, we aimed in our trial to study the e...

Bioequivalence Study of Rivaroxaban From Repatoxaban 10 mg Tablets (Horus for Pharmaceutical Industries, Egypt) and Xarelto® 10 mg Tablets (Janssen Pharm., Licensed From: Bayer Healthcare, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Rivaroxaban from Repatoxaban 10 mg Tablets (Horus for Pharmaceutical Indust...

Vaccination Education Through Pharmacists and Senior Centers (VEPSC)

The study consists of two arms (PHARM and PEER) designed to educate participants about three vaccine-preventable diseases (zoster, pneumonia, and influenza) and vaccination. PHARM will con...

Personalized Health Assessment Related to Medications (Project PHARM)

This research will adapt an evidence based intervention for alcohol and other drugs and evaluate its efficacy on Prescription Stimulant Medication (PSM) misuse in web-based and in-person f...

Epidogs International Inventory of Seizure Alert Dogs

This international research project looks at the reliability of canine seizure alerting behaviour in epilepsy patients. In the first stage an international database to identify the size an...

Companies [1344 Associated Companies listed on BioPortfolio]

Pharm-Olam International Ltd.

Pharm-Olam International is a multi-national contract research organization offering a wide range of comprehensive, clinical research services to the pharmaceutical, biotechnology...

Pharm-Olam International LLC

Pharm-Olam International is a multinational Contract Research Organization (CRO) offering comprehensive clinical research services to the pharmaceutical, biotechnology and medical...

Pharm-Olam International

Pharm-Olam International started operations in 1994 with the premise of delivering cost-effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, ...

NP Pharm

Founded in January 1992, NP Pharm is a private company, part of the Pharmaceutical group ETHYPHARM, which is one of the world leading companies for Drug Delivery Systems (DDS). Based, on a large exper...

Beijing Med-Pharm Corp

Beijing Med-Pharm offers an end-to-end solution to U.S and western pharmaceutical companies wishing to sell their products in China. We offer sales and marketing services throughout China and can help...

More Information about "Pharm-Olam International" on BioPortfolio

We have published hundreds of Pharm-Olam International news stories on BioPortfolio along with dozens of Pharm-Olam International Clinical Trials and PubMed Articles about Pharm-Olam International for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pharm-Olam International Companies in our database. You can also find out about relevant Pharm-Olam International Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record